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Abstract: Antibody-based sensors permit the rapid and sensitive analysis of a range of 
pathogens and associated toxins. A critical assessment of the implementation of such 
formats is provided, with reference to their principles, problems and potential for ‘on-site’ 
analysis. Particular emphasis is placed on the detection of foodborne bacterial pathogens, 
such as Escherichia coli and Listeria monocytogenes, and additional examples relating to 
the monitoring of fungal pathogens, viruses, mycotoxins, marine toxins and parasites are 
also provided. 
Keywords:  pathogen; antibody; biosensor; electrochemical; surface-plasmon resonance; 
assay development 
 
1. Introduction  
 
Pathogenic bacterial, fungal and viral cells are ubiquitous in nature and pose a considerable risk to 
human and animal health, in addition to severely compromising the quality of agricultural produce 
(Table 1). Therefore, the monitoring of these microorganisms is of paramount importance for the 
prevention of nosocomial infections, the maintenance of general public health and for ensuring 
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compliance with legislative and quality standards. The rapid detection and identification of a pathogen 
is essential, in particular where food samples with short shelf-lives are being analysed, or where the 
urgent administration of a suitable antimicrobial agent is required to treat a potential fatal infection. 
Virulent pathogens may often be present in low numbers in samples, demonstrating that high 
sensitivity and specificity are also absolute necessities. Hence, developing suitable detection methods 
which permit accurate, rapid and sensitive analysis is essential for monitoring the distribution of 
pathogens and, most importantly, ensuring customer/patient safety.  
Table 1. A selection of pathogenic bacterial, fungal and viral strains and their virulence traits. 
Pathogen Pathogenic  trait 
Bacterial Pathogens   
Bacillus anthracis  Human pathogen; causative agent of anthrax; toxin producer 
Bacillus subtilis  Putative human pathogen: causative agent of food poisoning 
Brucella abortus  Human and animal pathogen; causative agent of brucellosis 
Campylobacter spp. and C. jejuni  Human pathogen; causative agent of campylobacteriosis 
Clostridium botulinum  Human pathogen; producer of neurotoxins and causative agent of botulism 
Escherichia coli O157:H7  Human pathogen; causative agent of foodborne illness and producer of toxins, such 
as verocytoxin or ‘shiga-like’ toxin 
Francisella tularensis  Animal pathogen; putative biohazard 
Legionella pneumophila  Human pathogen; causative agent of Legionnaires disease (legionellosis) 
Listeria monocytogenes  Human pathogen; causative agent of listeriosis 
Mycobacterium tuberculosis  Human pathogen; causative agent of tuberculosis 
Neisseria meningitidis  Human pathogen; causative agent of bacterial meningitis 
Salmonella typhimurium  Human pathogen; causative agent of salmonellosis 
Staphylococcus aureus  Human pathogen; causative agent of hospital-acquired infection, toxin producer 
Yersinia enterocolitica  Human pathogen; causative agent of yersiniosis 
Yersinia pestis  Human pathogen; potential causative agent of the black plague  
Fungal pathogens   
Candida albicans  Human pathogen; causative agent of vaginal thrush 
Puccinia striiformis  Plant pathogen; causative agent of stripe rust 
Phytophthora infestans  Plant pathogen; causative agent of potato blight 
Trichophyton rubrum  Human pathogen; causative agent of athlete’s foot and ringworm 
Viral pathogens   
African swine fever virus  Animal pathogen; causative agent of African swine fever 
Bovine diarrhoea virus   Animal pathogen; causative agent of mucosal erosion and bovine diarrhoea 
Cowpea mosaic virus   Plant pathogen; causes mosaic pattern, vein yellowing and leaf malformation 
Ebola virus  Human pathogen; causative agent of severe haemorrhagic fever disease 
Foot and mouth virus  Animal pathogen; causative agent of acute degenerative disease in cattle 
Hepatitis C virus  Human pathogen; causative agent of blood-borne infectious disease 
Human immunodeficiency virus   Human pathogen; causative agent of acquired immunodeficiency syndrome (AIDS) 
Rift valley fever virus  Animal pathogen; causative agent of Rift valley fever 
SARS-associated coronavirus  Human and animal pathogen; causative agent of severe acute respiratory syndrome  
Tobacco mosaic virus  Plant virus; causes mottling and discolouration of leaves 
West Nile virus  Human and animal virus; causative agent of West Nile fever and encephalitis Sensors 2009, 9                  
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Figure 1. Strategy for pathogen detection. 
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This review provides a comprehensive summary of the principles, problems and potential of using 
immunosensor-based analytical platforms for pathogen detection. It describes the development of 
electrochemical, potentiometric, piezoelectric and optical platforms for the monitoring of foodborne 
bacterial pathogens by incorporating monoclonal, polyclonal or recombinant antibodies in a variety of 
different assay formats. The overall strategy adapted is shown in Figure 1. The analysis of fungal cells, Sensors 2009, 9                  
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associated toxic secondary metabolites, viral and water-borne pathogens (toxins and parasites) is also 
outlined. Finally, the advantages of using sensor-based methodologies as an alternative to more 
traditional methods of pathogen detection, namely bacteriological testing and nucleic acid-based 
analysis, and alternative sensor-based formats (e.g. biomimetic and plant sensors), will be discussed. 
 
2. Bacteriological and Nucleic Acid-Based Analysis of Pathogenic Bacteria: A Traditional 
Approach 
 
The culturing of pathogenic and non-pathogenic prokaryotic strains involves the aseptic transfer of 
an innoculum from a source (soil, food etc.) to suitable growth medium which results in amplification 
of microbial cell numbers, subsequently permitting quantitative determination [1]. This propagation 
may be performed in the presence of selective markers, such as antibiotics, to suppress the growth of 
other strains that may also reside in the innoculum. Subsequent transfer to selective or differential 
media generates colonies that can be distinguished based on their distinctive colony morphologies by 
ocular inspection (Table 2) and their identification confirmed by rigorous biochemical (glucose 
utilisation etc.) or nucleic acid-based assays [2]. 
Table 2. Three commonly encountered bacterial foodborne pathogens with their selective 
media and epidemiological relevance. Figures obtained for annual estimated cases and 
infectious doses (*) are obtained from reference [3] and are representative of figures 
calculated by the United States Department of Agriculture (USDA) economic research 
service. Key: CFU - colony-forming units. 
Strain and 
morphology 
Selective media  Clinical signs of 
infection 
Estimated 
annual cases *
 
Infectious doses 
(CFU) 
* 
E. coli O157:H7 
Gram negative rod 
 
Cefixime rhamnose sorbitol 
MacConkey agar [4] 
SEL media [5]. 
Diarrhoea (bloody) 
Renal failure 
Haemolytic uraemic 
syndrome (rare) 
173,107  1 × 10
1 - 1 × 10
2 
Salmonella spp. 
Gram negative rod 
Bismuth sulphide agar [4] 
SEL media [5] 
Cramps 
Diarrhoea 
Vomiting 
1,342,532  1 × 10
4 - 1 × 10
7 
L. monocytogenes 
Gram negative rod 
 
Listeria enrichment broth [4,6] 
Fraser broth [4] 
SEL media [5] 
Vomiting 
Abdominal cramps  
Fever 
2,493  400 - 1 × 10
3 
 
Colony count estimation provides an inexpensive and user-friendly protocol for quantitative and 
qualitative bacterial pathogen detection, and one which is routinely employed in the development of 
hazard analysis and critical control point (HACCP) systems within the food industry and for the 
establishment of risk assessments [2,7]. However, a major disadvantage of this approach is the lengthy 
times required to obtain visible colonies that can be identified. This may take up to 7 days for L. 
monocytogenes cells, cultured using the NF EN ISO 11290-1 protocol [3,8], and over 2 weeks for 
another important food-related pathogen, Campylobacter fetus  [9]. Further complications with using 
this methodology arise from the ability of some bacterial strains to be viable but non-culturable. This Sensors 2009, 9                  
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phenomenon, and its importance from the perspective of the food industry, has recently been discussed 
with reference to L. monocytogenes [10] and E. coli O157:H7 [11]. 
An alternative method for pathogen detection, and one which is often used in conjunction with 
active culturing to provide sufficient biomass, involves the amplification and subsequent analysis of 
pathogen-specific nucleic acid by polymerase-chain reaction (PCR) and sequencing (Table 3). The 
versatility of these methodologies is emphasised by the ability of real-time PCR to provide rapid data 
analysis of multiplex PCR to facilitate the simultaneous analysis of multiple pathogens and of reverse-
transcriptase PCR to differentiate between viable and non-viable cells. Furthermore, the presence of 
bacterial RNAs (mRNA and tmRNA) in food samples can be determined through the use of nucleic-
acid sequence-based amplification (NASBA) [12,13]. However, the implementation of these 
methodologies for pathogen detection can be complicated by external factors. For example, strains 
may originate from complex sample matrices, e.g. food sources that often contain high levels of fats, 
carbohydrates and other entities which necessitate a sample clean-up stage prior to analysis. 
Furthermore, as discussed by De Boer and Beumer [7], the amplification of nucleic acid from a 
pathogenic strain is indicative only of its presence in the sample of interest and cannot be used to 
monitor toxin production qualitatively or quantitatively. Non-specific DNA amplification may also be 
observed; the presence of ‘naked’ DNA in analytical samples may act as a template for the 
amplification of these superfluous products [14] which complicates fingerprint-based analysis. 
Therefore, alternative methods of pathogen analysis (e.g. antibody-based) can be more useful. 
Table 3. A selection of nucleic acid-based protocols for pathogen detection. 
Technique Pathogen  application  Ref. 
Real-time PCR  Mycobacterium avium subsp. Paratuberculosis 
E. coli O157:H7 
S. aureus 
L. monocytogenes 
S. enterica serovar typhimurium 
[15] 
[16] 
[17] 
[8,18] 
[19] 
Multiplex PCR  E. coli O157:H7; Salmonella spp.; Shigella spp. 
L. monocytogenes and Salmonella spp. 
Campylobacter  spp., Sal monella  spp.,  E. coli ,  Shigella  spp.,  Vibrio 
cholerae, Y. enterocolitica 
[20] 
[21] 
[22] 
Reverse transcriptase PCR  E. coli O157:H7 
E. coli O157:H7, V. cholerae, S. typhi 
[23] 
[24] 
Immuno PCR  Streptococcus pyogenes 
E. coli shiga-toxin 2 
[25] 
[26] 
NASBA  L. monocytogenes 
Campylobacter spp., L. monocytogenes, S. enterica serovar Enteritidis 
[12,13] 
[27] 
 
3. Antibodies: Production and Purification 
 
A schematic representation of a full-length antibody is shown in Figure 2. Polyclonal, monoclonal 
and recombinant antibodies have frequently been selected for a wide variety of applications, including 
immunodiagnostics and biomarker detection. Their production involves the exploitation of the immune 
system of murine, leporine, ovine or avian hosts (Figure 3A). For the production of bacterial pathogen-Sensors 2009, 9                  
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specific antibodies, these hosts may be immunised with cells which may [28] or may not [6] be heat-
treated (exceptions include naïve antibody phage display libraries which are constructed independently 
of immunisations; see below). These antigens are typically administered in the presence of a suitable 
adjuvant, and the immune response generated by the host after a series of immunisations can be 
determined by screening serial serum dilutions for recognition of the antigen in an enzyme-linked 
immunosorbent assay (ELISA)-based format.  
Figure 2. A schematic representation of an IgG antibody comprising of two heavy (green) 
and light (blue) chains. Carbohydrate elements are attached via the asparagine 297 amino 
acid residue. A more in-depth discussion of antibody glycosylation is provided in 
reference [30]. Key: VH – variable heavy, VL – variable light, CH – constant heavy, CL – 
constant light. 
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3.1. Polyclonal Antibodies 
 
Polyclonal antibodies (pAb) are typically raised in rabbits, goats or sheep [29], and their popularity 
is illustrated by the fact that they are frequently selected in immunosensor-based assays for pathogen 
detection. It should be stressed that the inherent nature of pAbs means that a selection of different 
epitopes may often be recognised on a single cell. In cases where this is undesirable, such as in the 
case where high specificity is a requirement, monoclonal or recombinant antibodies may be more 
applicable. 
 
3.2. Monoclonal Antibodies 
 
Monoclonal antibodies are generated through the use of hybridoma technology [31,32] and murine 
hosts are commonly selected for immunisation. The bone marrow, primary lymph nodes and, most 
commonly, the spleen are selected as a source of antibody-producing B cells which are harvested and 
fused to immortal myeloma cells. The resulting hybrid cells (referred to as hybridomas) subsequently 
secrete full-length antibodies that are directed towards a single epitope. Suitable candidates, identified 
by ELISA-based analysis, are then ‘cloned out’ to ensure that a single cell, producing antibody specific 
for an individual epitope, is present and the antibody generated can be used for assay development.  Sensors 2009, 9                  
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3.3. Recombinant Antibodies 
 
Recombinant antibodies, generated through the use of phage display technology and the biopanning 
of antibody repertoires (libraries) against a target of interest [33,34], have been selected for the 
detection of a range of structurally diverse antigens, including proteins [35], haptens [36] and 
carbohydrate moieties [37]. Three types of library may be used as sources of antibody pools; namely 
synthetic, naïve and immune. Synthetic libraries are produced by PCR-based randomisation of 
complementarity-determining regions (CDR) from heavy and/or light chains, and naïve antibody 
libraries are typically assembled from B-cells extracted from unimmunised human donors. Immune 
libraries are constructed from RNA isolated from spleenocytes or the bone marrow of a host (avian, 
murine, leporine etc.) immunised with an antigen that generates the required immune response. The 
RNA acts as a source of complementary DNA (cDNA) which, in turn, serves as a template for the 
amplification of variable heavy (VH) and variable light (VL) gene sequences which can be fused 
through an overlapping-extension splicing PCR reaction and subsequently cloned into a suitable phage 
or phagemid vector (Figure 3A) [note that in the case of fragment antigen binding (Fab) construction 
(see below), this process involves the fusion of variable and constant regions]. The introduction of this 
construct into suppressor strains of E. coli (such as XL1 Blue) by electroporation, in conjunction with 
the packaging of phage particles via the addition of helper phage (a process referred to as rescuing), 
allows the encoded antibody structure to be ‘presented’ on the exterior of a bacteriophage particle, as 
illustrated in Figure 3B. Two types of antibody fragments may be presented, namely the single-chain 
variable fragment (scFv) and the Fab, and these are illustrated in Figure 3C and 3D. The production of 
these fragments is dependent on the vector selected for harbouring the library [38]. 
Biopanning is used for the selection of binders from an antibody library which may contain between 
10
7 and 10
10 different antibody-encoding gene sequences. To achieve this, the antigen is immobilised 
on solid phase (e.g. on a column or immunotube) or bead-conjugated (in solution phase) and the 
antibody pool is subjected to recurrent rounds of selection against the antigen with increasing levels of 
stringency in terms of binding ability. Selected binders are retained and subjected to additional 
screening to increase their specificity for the target (affinity maturation), which can be monitored by 
ELISA-based analysis. The production of soluble antibody fragments can be facilitated by infecting 
phage pools into non-suppressor E. coli  strains, such as Top-10F’ or HB2151, and inducing with 
isopropyl-β-D-1-thiogalactopyranoside (IPTG) in the presence of low concentrations of glucose. These 
hosts recognise the amber (AUG) codon engineered between the scFv and gIII gene [39], producing 
scFv or Fab fragments independent of the phage coat proteins.  
The majority of the examples given in this review involving immunosensor-based pathogen 
detection incorporate monoclonal or polyclonal antibodies. However, recombinant antibodies are as 
yet not fully exploited in this field and have several significant advantages over conventional 
antibodies. The specificity and sensitivity of recombinant antibodies for a particular antigen can be 
significantly enhanced by the targeting of CDR regions using site-directed mutagenesis or chain 
shuffling [40,41]. Further advantages include the capacity to incorporate tags (e.g. His or C-myc) for 
isolation and, subsequently, immobilisation, the ability to fuse various labels (e.g. green fluorescent 
protein or enzymes) directly to the antibody fragment facilitating and simplifying detection, and the 
availability of a range of antibody formats (e.g. scFv, Fab, re-engineered IgG, dimers etc.). Avian Sensors 2009, 9                  
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hosts, in particular, have been shown to be useful for the production of high-affinity recombinant 
antibodies [35,42,43]. 
Figure 3. An overview of monoclonal, polyclonal and recombinant antibody production 
[A]. Immunisation-related stages are represented by a red line, with those involving 
antibody production shown in black. A more in-depth discussion of the generation of 
recombinant antibodies, inclusive of Fab fragments, can be found in reference [38]. 
Additional hosts may also be used for antibody production, including camels (camelid), 
sheep (ovine) and pigs (porcine). A filamentous phage displaying scFv antibody fragments 
[B] and two recombinant antibody fragments, the scFv [C] and Fab [D], are also illustrated. 
Key: pIII/pVIII – protein 3/8, VH – variable heavy, VL – variable light. 
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4. Antibody Selection 
 
When selecting monoclonal, polyclonal or recombinant antibodies for the detection of pathogens, 
certain characteristics are of great importance. Firstly, the antibody should be able to detect and 
quantify very low cell numbers (sensitivity) and this may frequently be an issue for foodborne-related 
bacterial pathogens (Table 2). 
Secondly, it should be able to differentiate specific strains of interest from related microflora which 
may also reside in the sample (specificity). Hence, the selection of a highly-specific epitope on the 
pathogen is a key consideration, since many bacterial strains share homologues of surface-presented 
proteins which can lead to the detection of multiple cell-types by a single antibody. It is therefore 
recommended that a constitutively-expressed antigen, which is species-specific, is targeted [3]. Where 
possible, the expression of this target antigen should not be highly dependent on the growth matrix of 
the pathogen. Finally, the antibody should bind with its cognate target with sufficient strength to 
permit interrogation (high-affinity). The identification of an antibody candidate that satisfies these 
requirements can be facilitated through screening by ELISA-based analysis to reduce the number of 
potential antibodies to a smaller number which can subsequently be screened by sensor-based analysis 
to identify the candidate with the best affinity for the target epitope. This antibody can then be further 
selected for incorporation on an immunosensor-based platform. 
 
5. Use of Antibodies for Antigen Isolation/Enrichment Prior to Analysis 
 
Antibodies can be successfully used to isolate and collect pathogens from complex matrices where 
numbers are low and the sample volume is large. Immunomagnetic separation (IMS) involves the 
coating of a pathogen-specific antibody on a magnetic bead which can be used to facilitate binding, 
concentration and removal of pathogenic cells from a complex sample media (provided that the 
antibody has sufficient specificity). Retrieved cells can then be propagated on selective of differential 
media. The versatility of this technique is further illustrated by the ability to detect pathogen-antibody 
complexes with beads coated with a cognate secondary antibody, an indirect assay format 
demonstrated by Torensma and co-workers [44] for the detection of L. monocytogenes cells bound to a 
murine monoclonal antibody produced from the immunisation with whole bacterial cells. IMS has also 
been applied for the detection of these cells in cheese [45], S. typhimurium in bovine faecal matter [46] 
and E. coli O157:H7 in beef carcasses [20,47] and bovine faeces [48].  
 
6. ELISA and Microarray-Based Pathogen Detection 
 
ELISA-based analysis can be directly applied for the detection of foodborne pathogens. Brooks and 
co-workers [9] developed an ELISA-based assay for the detection of C. fetus  in bovine preputial 
washing and vaginal mucous samples. A sandwich assay format was developed by Kerr et al. [49] for 
the detection of a selection of different E. coli O157:H7 strains from human and animal subjects by 
using a monoclonal antibody specific for a fimbrial antigen. The limit of detection was similar to that 
found by Brooks et al. (1 × 10
5 CFU/mL). ELISA-based assays have also been described for the 
detection of L. monocytogenes [50,51] and Salmonella enterica spp. [52]. A major drawback of these Sensors 2009, 9                  
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assay formats is that analysis times are often lengthy. Typical ELISA assays are comprised of a 
number of steps; namely blocking, washing, incubation of primary and secondary antibodies and 
substrate development. These can take several hours to complete and, understandably, this may be 
problematic in instances where rapid detection is a requisite.  
Protein microarrays are excellent candidates for high-throughput analysis of biomolecular 
interactions in miniaturised assays formats [53]. The implementation of antibodies on such platforms 
for pathogen detection offers a flexible approach for the screening of high number of bacterial isolates 
from numerous sample matrices. Array formats typically consist of a panel of pathogen-specific 
antibodies spotted onto individual positions on a microarray slide by dedicated robotic handling 
(printing), with subsequent pathogen detection commonly employing sandwich ELISA assay formats. 
Gehring and colleagues [54] printed a biotinylated antibody (caprine-derived) for E. coli O157:H7 on a 
streptavidin-coated microarray slide. Captured cells were further probed with a fluorescein-labelled 
secondary antibody and microarray spots were visualised through the use of fluorescent microscopy. 
This sandwich assay format had a linear range of detection of 3 × 10
6 - 9 × 10
7 cells/mL. Cai et al. [55] 
developed an antibody microarray capable of the parallel analysis of somatic (O) and flagellar (H) 
antigens on 117 Salmonella  strains from twenty commonly encountered serovars, including 
typhimurium, heidelberg and enteritidis. Thirty five polyclonal antibodies from rabbit antiserum were 
spotted in pairs on commercially obtained microarray slides and used for the capture of Eosin Y-
fluorescently labelled cells. Over 73% of the strains selected for analysis were positively identified, 
with an additional 30 strains partially serotyped. The ability of this assay format to selectively 
differentiate between related and unrelated Salmonella strains was demonstrated by the analysis of an 
additional 73 strains selected from a panel of almost forty non-target serovars. Anjum et al. [56] also 
targeted O-antigen groups of 17 E. coli strains with rabbit polyclonal antisera. The ability of these 
microarray formats to screen numerous bacterial pathogens in parallel was further illustrated by the 
printing of individual antibodies in a 96-well polystyrene plate by an ‘in-house’ robotic printing 
system. This cost-effective array format, devised by Gehring and colleagues, was selected for the 
simultaneous detection of E. coli (1 × 10
6 cells/mL) and Salmonella typhimurium (1 × 10
7 cells/mL) in 
buffer and ground beef extract [57] and further illustrates the versatility of such antibody-based 
formats. Finally, antibody-based microarray platforms have been selected for the sensitive and parallel 
detection of structurally diverse pathogens. These include bacterial strains that pose a potential bio-
terrorism risk (e.g. Burkholderia mallei, F. tularensis and Y. pestis) and viral particles (e.g. West Nile 
virus) [58], foodborne pathogens (Campylobacter jejuni ) and mycotoxins [59] and, finally, spore-
forming bacterial cells (B. globigii) and toxins [60]. The latter assays [59,60] implement the Naval 
Research Laboratory (NRL) array biosensor. This elegant platform can simultaneously detect 
pathogenic bacterial cells and toxins, and can perform sandwich (as is the case with many of these 
examples) and competition immunoassays in parallel with an assay time of approximately 
15 minutes [59]. Toxin and virus-related pathogen detection is discussed in sections 13 and 14 with 
reference to immunosensor-based analysis. 
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7. Biosensors 
 
Biosensors are analytical devices which combine a biological recognition ligand with physical or 
chemical signaling devices (transducers). The recorded biomolecular interactions are transformed into 
digital signals which are interpreted by a computer-aided readout, thereby providing the user with a 
representation of the interaction that occurs between the bound (ligand) and free (analyte) entities 
(Figure 4). Many different sensor formats have been utilised for pathogen analysis using antibodies; 
namely electrochemical, mass-based, magnetic and optical. The sensitivities of these assays are 
dependent on the properties of the transducer and the quality of the antibody. An overview of each 
sensor type and an explanation of how antibodies can be incorporated for pathogen detection follows. 
Figure 4. A simple representation of a biosensor. Here, a full-length antibody is captured 
on protein A immobilised on a carboxymethylated dextran-coated sensor surface and is 
used for the capture of an analyte. This interaction produces a specific physicochemical 
change, such as a change in mass, temperature or electrical potential. This is then 
converted (via a transducer) to a signal which the user can interpret. 
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8. Electrochemical Immunosensors 
 
The principle behind these assay formats is the coupling of a specific antibody with an electrode 
transducer which functions to convert a binding event into an electrical signal. In general, 
electrochemical biosensors can be based on four transducer types; namely amperometric, 
impedimetric, potentiometric and conductimetric.  
 
8.1. Amperometric Platforms 
 
Many amperometric biosensors utilise an enzyme-based system that generates an electroactive 
product which can be oxidised or reduced at a working electrode (carbon, gold etc.). The resultant 
current can then be detected. This format has several advantages, including the capacity to fabricate 
disposable and customised screen-printed electrochemical electrodes (screen-printed carbon 
electrodes) by depositing inks (carbon, silver etc.) in a pre-determined arrangement and thickness [61]. 
These systems are economical, robust and sensitive and can be used in conjunction with mediators 
such as ferrocenedicarboxylic acid (FEDC) or iodine to improve selectivity [3]. Furthermore, there is 
major potential to miniaturise these systems. This leads to smaller sample volume requirements.  Sensors 2009, 9                  
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Gehring et al. [62] developed an amperometric assay for the detection of S. typhimurium cells 
which were captured with magnetic bead-conjugated antibodies and detected with an alkaline-
phosphatase (AP)-labelled goat anti-Salmonella antibody. After deposition of the beads on graphite ink 
electrodes, the AP-catalysed production of electroactive para-aminophenol (PaP) from its substrate, 
para-aminophenyl phosphate (pAPP), was monitored electrochemically and the generated signal was 
directly proportional to the number of captured bacterial cells. This assay had a sensitivity of 8 × 10
3 
cells/mL. Ivnitski and co-workers [63] also applied this methodology for the detection of 
Campylobacter. Here, anti-Campylobacter antibodies were embedded in a bilayer lipid membrane and, 
upon binding with free cells, a conformational change was introduced which allowed the transport of 
ions through the membrane. The resultant current was detected amperometrically via a stainless steel 
electrode. This rapid (10 minutes) assay allowed the researchers to verify that 10
10 ions could pass 
through the channel per second. This value was correlated with a theoretical value of one bacterial cell 
per sample. Lin and co-workers [64] recently immobilised a monoclonal antibody on screen-printed 
carbon electrodes (SPCE) for the capture of pure cultures of E. coli O157:H7, and implemented a 
horseradish peroxidase (HRP)-labelled polyclonal antibody for detection in an indirect sandwich assay 
format. It was noted that the attachment of gold nanoparticles and the use of FEDC, as a mediator, 
resulted in a noticeable amplification of the response current generated. This enabled the detection of 
approximately 5 × 10
3 CFU/mL in 1 hour. The assay had excellent selectivity and specificity, with 
minimal cross-reactivity observed when groups of other food pathogens were tested in parallel (L. 
monocytogenes,  Salmonella choleraesuis  and  Vibrio paraheamolyticus ), thus illustrating the 
importance of having a selective biorecognition element. Crowley and colleagues [65] also selected a 
SPCE-based platform for L. monocytogenes detection. A direct sandwich assay format, consisting of a 
leporine polyclonal capture antibody and an AP-labelled detection antibody, could detect 
9 × 10
2  cells/mL. Comparable sensitivity was observed when polyclonal goat (1  ×  10
3 cells/mL) 
andrabbit (9 × 10
2 cells/mL) antibodies were used for capturing cells in an indirect sandwich assay 
format. The direct immobilisation of L. monocytogenes cells on the SPCE provided a low response.  
 
8.2. Impedimetric Platforms 
 
Impedimetric biosensors are often based on the fact that the metabolic redox reactions of 
microorganisms are detectable and quantifiable when performed in the presence of a suitable 
mediator  [66]. Hence, viable microbial biomass can be determined by monitoring microbial 
‘metabolism’ which, in turn, increases conductance and capacitance and results in a decrease in 
impedance. Similarly to amperometric biosensors, several elegant antibody-based impedimetric assays 
have been used for pathogen detection. Radke and Alocilja [67] developed a high-density 
microelectrode array for the sensitive detection of E. coli O157:H7 (1 × 10
4 – 1 × 10
7 CFU/mL) using 
a goat anti-IgG polyclonal antibody for capture. Tully and colleagues recently implemented a 
biotinylated leporine polyclonal antibody for the detection of internalin B (InB), a L. monocytogenes 
cell-surface protein. When captured on avidin-coated planar carbon electrodes modified with 
polyaniline, a conductive polymer, the limit of detection for InB was found to be 4.1 pg/mL [68]. The 
versatility of using this approach for the detection of this bacterium was also illustrated by Wang 
et al. [69] who adopted a different protocol by immobilising a monoclonal antibody on a titanium-Sensors 2009, 9                  
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dioxide nanowire to detect 1 × 10
2 CFU/mL. Finally, Su and Li [70] demonstrated how a quartz crystal 
microbalance (QCM) system using impedance could detect S. typhimurium  in chicken meat. The 
implementation of magnetic beads resulted in a significant improvement in assay sensitivity, with a 
limit of detection of 1 × 10
2 cells/mL. Minimal cross-reactivity was observed with E. coli. 
 
8.3. Potentiometric Platforms 
 
In potentiometric biosensors the conversion of a biorecognition process into a change in potential 
signal is detected by a reference electrode. Potentiometric biosensor formats typically consist of a 
perm-selective outer layer and a bioactive element, such as urease, may be introduced to enhance the 
performance of the assay [3]. A methodology that combines potentiometric and optical detection, 
namely the light-addressable potentiometric sensor (LAPS), was shown to be applicable for pathogen 
detection. Gehring et al. [71] implemented this technology in conjunction with an immune-ligand 
assay (ILA) for the detection of E. coli O157:H7. The assay format devised involved the enumeration 
of cells by biotinylated polyclonal capture and fluorescein-labelled detection antibodies which were 
raised in caprine hosts through the administration of heat-killed cells. This ‘sandwich’ complex (in the 
presence of an additional urease-labelled anti-fluorescein antibody) was subsequently captured on a 
streptavidin-bovine serum albumin (BSA)-coated nitrocellulose membrane. Urease enzymatic activity 
was monitored by the hydrolysis of urea to carbon dioxide and ammonia. The authors were able to 
detect approximately 7.1 × 10
2 cells/mL and 2.5 × 10
4 cells/mL of heat-killed and live cells of E. coli, 
respectively, in buffered solutions. Dill and co-workers [72] utilised a silicon chip-based LAPS assay 
to detect low levels (119 CFU) of S. typhimurium. Here, biotinylated and fluorescein-labelled anti-
Salmonella antibodies were selected as biorecognition elements. This assay format was subsequently 
applied for the monitoring of chicken carcass washings spiked with Salmonella  cells, and 
demonstrated a high recovery rate for cells (90%).  
 
8.4. Conductimetric Platforms 
 
The final electrochemical immunosensor format that will be discussed, with reference to the 
detection of E. coli and Salmonella spp., is based on conductimetric detection [73]. Here, a biological 
signal is converted to an electrical signal via a conductive polymer, such as polyacetylene, polypyrrole 
or polyaniline. Muhammad-Tahir and Alocilja [74] developed a conductimetric biosensor 
incorporating a polyclonal antibody-based sandwich assay format in which the detection antibody was 
labelled with polyaniline. This sensor could detect approximately 79 CFU/mL and 83
 CFU/mL of E. 
coli O157:H7 and Salmonella spp., respectively. This approach was also used for the detection of E. 
coli cells in a selection of different sample matrices, including lettuce and strawberries [75]. The 
sensitivity recorded was 81 CFU/mL. Furthermore, the assay was rapid (6 minutes) and could be 
generated in a disposable format.  
Hnaiein and co-workers [76] developed a novel conductimetric immunosensor for E. coli . A 
biotinylated polyclonal antibody was captured on streptavidin-coated magnetite nanoparticles. These 
were subsequently bound on a conductimetric electrode through the use of glutaraldehyde coupling. 
Conductimetric measurements were facilitated through the application of an alternating-current (ac) Sensors 2009, 9                  
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voltage. The incorporation of nanoparticles facilitated an increase in conductivity, enabling 
0.5 CFU/mL to be detected. A small amount of background was observed when S. epidermis  cells 
were assayed in parallel. This was attributed to the use of a polyclonal capture antibody and reinforces 
the view that in some assay formats, monoclonal or recombinant antibodies may be more suitable. 
 
9. Mass-Based Immunosensors 
 
Piezoelectric biosensors operate on the principle that a change in mass, resulting from the 
biomolecular interaction between two entities, such as an antibody and its respective antigenic 
determinant, can be determined [77]. For example, in a quartz crystal, mass changes result in 
alterations in resonance frequency. Piezoelectric immunosensors are affordable and disposable options 
for pathogen detection, and the implementation of QCM for the direct detection of analytes, such as 
bacterial cells, alleviates the need for labelled secondary antibodies [78]. Babacan and co-workers [79] 
demonstrated that the use of protein A for the capture of a polyclonal antibody to S. typhimurium 
enhanced reproducibility and surface stability when compared to polyethyleneimine-glutaraldehyde 
(PEI-GA) coupling. The resultant assay format permitted the detection of 1.6 × 10
9 CFU/mL.  
Fung and Wong [80] described how the use of ethyl-N`-(3`dimethylaminopropyl)-carbodiimide 
hydrochloride (EDC) and N-hydroxysuccinimide (NHS) coupling, a methodology routinely selected 
for the immobilisation of ligands on optical sensor platforms, allowed the capture of a monoclonal 
antibody for S. paratyphi A. The use of this surface immobilisation chemistry was shown to provide 
good stability and sensitivity, with a limit of detection of 1.7 × 10
2 cells/mL. With respect to both of 
these formats and previously mentioned assays involving protein A immobilisation [70], the selection 
of a proper strategy for correctly orientating antibodies is conducive to enhanced sensitivity and 
selectivity. Kim and co-workers [81] used a QCM platform based on impedance measurement for the 
detection of S. typhimurium (the limit of detection was approximately 1 × 10
3 CFU/mL). Su and Li 
[78] developed a piezoelectric sensor for detecting between 1 × 10
3 to 1 × 10
8 CFU/mL of E. coli 
O157:H7 through the implementation of antibodies on a QCM via a 16-mercaptohexanedecanoic acid 
(MDHA) monolayer. Pohanka et al. [82] used a polyclonal antibody linked to the piezoelectric crystal 
surface using glutaraldehyde to detect E. coli. The resulting assay was rapid, permitting analysis in ten 
minutes (inclusive of a regeneration step for re-analysis), and greater than ten assays could be 
performed without the need for re-calibration. This ‘label-free’ assay had a limit of detection of   
1 × 10
6 CFU/mL. 
 
10. Thermometric and Magnetic Immunosensors 
 
In therometric biosensors thermistors are frequently selected as temperature transducers [83]. 
Magnetic biosensors, in contrast, implement magnetic beads coated with a suitable ligand that can be 
detected within a magnetic field. From the perspective of bacterial pathogen detection, the latter 
platforms have been explored to a greater degree than their thermometric counterparts. Magnetic 
systems offer distinct advantages. For example, when a sample selected for analysis does not contain 
any contaminating materials with magnetic properties, background signals (non-specific) are 
minimised. Ruan and colleagues [84] immobilised anti-E. coli  antibodies on a magnetoelastic Sensors 2009, 9                  
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cantilever through the construction of a self-assembled monolayer (SAM). The principle of this assay 
was the conversion of a substrate, 5-bromo-4-chloro-3-indolyl phosphate (BCIP), to an oxidised and 
insoluble blue precipitate via an AP-catalysed reaction (secondary antibody). This product 
accumulated on the sensor surface, and the resulting changes in resonance frequency were recorded, 
facilitating the detection of 1 × 10
2 cells/mL of E. coli O157:H7. Mujika et al. [85] recently developed 
a magnetoresistive sensor for the detection of E. coli. It consisted of a sandwich assay whereby the 
bacterial cells were captured with a polyclonal antibody and detected using leporine polyclonal 
antibodies coated on superparamagnetic beads. The application of an external magnetic field was used 
for monitoring. This assay had a sensitivity of 1 × 10
5 CFU/mL of E. coli  O157:H7. Furthermore, 
minimal cross-reactivity was seen when S. choleraesuis was tested on this format. With reference to 
immobilisation strategies, when comparative analysis was performed between three different materials, 
silicon nitride was found to be more suitable than silicon dioxide (SiO2) and SU-8 for antibody 
capture. Finally, this sensor format was hand-held, and these miniaturised formats demonstrate one 
approach for ‘on-site’ pathogen detection. 
In conclusion, electrochemical, piezoelectric and magnetic immunosensors can all be applied to 
foodborne pathogen detection. Optical platforms also offer a powerful and ‘label-free’ methodology 
that permits ‘real-time’ pathogen detection, and these are discussed in section 11. 
 
11. Optical Immunosensors 
 
Surface-plasmon resonance (SPR) is a phenomenon that results from the illumination of a metallic 
surface, such as gold, by visible or near-infrared radiation from a monochromatic light source via a 
hemispherical prism which exits to a detector (photodiode array) at an angle related to the refractive 
index (RI). The resultant oscillation of free electrons generates surface plasmons (electromagnetic 
waves) which resonate and absorb light. The specific wavelength/angle at which this occurs is a 
function of the RI in the proximity of the gold surface and relates to the mass on the chip surface. A 
change in mass, effected by the immobilisation of a ligand and, subsequently, further interactions 
which take place when analytes are passed over the modified sensor surface, causes a shift in the 
resonance to a longer wavelength and, hence, introduces a refractive index change (Figure 5).  
A large selection of commercially available optical biosensors can be directly applied for pathogen 
detection. Wei et al. [88] used the SPREETA
TM SPR system (Texas Instruments) for the detection of 
Campylobacter jejuni. Here, biotinylated leporine polyclonal antibodies were immobilised directly on 
the sensor surface and the assay had a sensitivity of 1 × 10
3 CFU/mL. Barlen and co-workers [89] 
selected the Plasmonic SPR device (Plasmonic Biosensoren) for the detection of Salmonella 
typhimurium (2.5 × 10
5 CFU/mL) and S. enteritidis (2.5 × 10
8 CFU/mL). Mazumdar and colleagues 
also selected the same biosensor system for the detection of S. typhimurium (1.25 × 10
5 cells/mL) in 
milk by implementing leporine polyclonal capture and detection antibodies [90]. A range of other 
optical sensor platforms, including the ProteOn XPR36 (Bio-Rad) and SensíQ (Nomadics) and 
Biacore
TM (discussed below) also have the potential to be applied for pathogen monitoring. Oh 
et al. [91] devised a SPR-based protein chip assay format with immobilised monoclonal antibodies 
against  S. typhimurium ,  E. coli  O157:H7, Yersinia enterocolitica  and  Legionella pneumophila . 
1 × 10
5 CFU/mL of each pathogen could be specifically detected with their respective antibody.  Sensors 2009, 9                  
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Figure 5. Representation of the SPR phenomenon, showing the Kretschmann prism 
arrangement originally proposed in references [86] and [87]. For illustrative purposes, a 
protein-A (green hexagon)-captured IgG antibody is shown on a carboxymethylated 
dextran (CM5) sensor surface. The mass change introduced by the binding of an analyte of 
interest (blue circle) is shown as a change in refractive index (A to B) which can be 
determined through the use of dedicated software. 
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Koubová et al. [92] were able to detect 1 × 10
6 CFU/mL of L. monocytogenes and S. enteritidis on 
an ‘in-house’ SPR system, while Taylor et al. [93] devised an eight-channel SPR sensor for permitting 
the detection of E. coli O157:H7 (1.4 × 10
4 CFU/mL), L. monocytogenes (3.5 × 10
3 CFU/mL), C. 
jejuni (1.1 × 10
5 CFU/mL) and S. choleraesuis  (4.4 × 10
4 CFU/mL) in buffer (PBS). Rijal and 
colleagues [94] applied a novel fibre-optic biosensor for the detection of E. coli  O157:H7 by 
immobilising a monoclonal antibody on a silanised (3-aminopropyl-triethoxysilane, APTES) silica 
fibre-tapered surface using EDC/sulpho-NHS coupling. Changes in light transmission (470 nm) were 
introduced by pathogen binding, and the assay had a sensitivity of 70 cells/mL. Alternative fibre optic-
based platforms that use fluorescent detection include the Analyte 2,000 [95] and the RAPTOR 
biosensor. The latter is a portable device that utilises a sandwich ELISA format for detecting 
pathogens. Typically, a biotinylated capture antibody is immobilised on an avidin-coated fibre-optic 
waveguide. Four such channels are housed within a plastic disposable ‘coupon’, thereby permitting 
parallel analysis to be performed with four different analytes. Detection antibodies are labelled with a 
fluorophore, typically cyanine 5 (Cy5) [96] or Alexa fluor 647 (AF647) [97]. Fluorescently-tagged 
molecules that are located within 100 – 1,000 nm of the waveguide surface are excited by a diode laser 
(635 nm), and a percentage of the emitted fluorescence is detected by an optical probe and quantitated 
by a photodiode detector that collects emitted light at wavelengths of over 650 nm [96]. The RAPTOR 
biosensor has been used for detecting foodborne pathogens, including S. typhimurium in spent water 
samples of spiked alfalfa seeds [98], L. monocytogenes  in frankfurter meat [99] and Enterococcus 
faecalis from recreational water samples [100]. Pathogens can also be recovered and propagated by 
incubating waveguides containing bound bacterial cells in selective media post-analysis [98].  Sensors 2009, 9                  
 
 
4423
These examples demonstrate the use of commercial and ‘custom-built’ SPR systems. A more 
detailed discussion of Biacore-based analytical approaches will now be provided, together with the 
problems encountered with these assay formats and methods for overcoming them. 
The versatility of Biacore-based analytical platforms is demonstrated by the ability of the researcher 
to perform capture, sandwich or subtractive-inhibition assays, as shown in Figure 6. Hearty and 
colleagues [6] produced a murine monoclonal antibody which was shown to be specific for the 
surface-located L. monocytogenes  internalin A (InA) protein in native and recombinantly-expressed 
forms. When this antibody was immobilised on a CM5 surface through EDC/NHS coupling, a limit of 
detection of 1 × 10
7 CFU/mL was observed when L. monocytogenes cells were tested. Cross-reactivity 
studies clearly demonstrated the specificity of this monoclonal antibody, with minimal binding to E. 
coli, B. cereus and Listeria innocua (the latter selected due to the non-expression of the InA protein) 
observed. This further illustrates the importance of this antibody as a species-specific reagent. 
Figure 6. SPR-based assays for pathogen detection. (A) Specific antibody is immobilised 
and is used to capture the pathogen leading to a signal. (B) Pathogen or pathogen-related 
antigen is captured. Specificity is conferred by the binding of a second antibody. (C) 
Specific antibody reacts with the pathogen or pathogen-related antigen. Non-bound (free) 
antibody is isolated and detected when bound to an immobilised antibody (normally an 
anti-species antibody) on the chip. In this case, the signal generated is inversely 
proportional to the pathogen concentration. 
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Sandwich assay formats are routinely selected for increasing sensitivity in ELISA-based analytical 
platforms. This format was adapted for SPR-based analysis of E. coli  O157:H7 and Salmonella by 
Fratamico and colleagues [101]. They demonstrated that the sensitivity of a capture assay for E. coli 
O157:H7 cells (5 × 10
9 CFU/mL) could be enhanced significantly by the subsequent addition of a 
caprine polyclonal antibody, which enabled the detection of between 5 and 7 × 10
7 CFU/mL.  
Another interesting observation deduced from this experimental work related to the immobilisation 
strategy. The initial experimental format implemented a capture assay format (5 × 10
9 CFU/mL). No 
apparent increase in sensitivity was observed when protein A was used to immobilise the mAb. The 
ability of a sandwich assay format to enhance sensitivity was also described by Bokken et al. [102] for 
the detection of Salmonella groups B, D and E. The original capture format permitted the detection of 
1 × 10
7 CFU/mL. This sandwich format used a monoclonal capture and polyclonal detection antibody, 
the former immobilised through standard EDC/NHS coupling. This assay format reduced the limit of 
detection to 1.7 × 10
5 CFU/mL. While these assays clearly illustrate the potential that sandwich 
formats have for increasing assay sensitivity, it should also be mentioned that this is not always 
successful, as shown by the inability of two anti-L. monocytogenes polyclonal antibodies to enhance 
the signal in an assay format where cells were originally captured by a mouse monoclonal antibody 
[6]. There are also additional concerns with using this sandwich format on Biacore-based platforms 
due to the large size of the bacterial cells which exceeds the penetration depth of an evanescent wave 
(see section 15). 
The subtraction inhibition assay (SIA) is an extremely useful method for pathogen detection in 
SPR-based immunoassays, and can be selected in instances where the user does not want to expose the 
system to pathogenic cells or to matrices which may have high viscosities. The principle of this assay 
format involves pre-incubating an antibody with a target pathogen and separating free from bound 
antibody. The quantity of free antibody is inversely proportional to the concentration of pathogen. 
Haines and Patel [103] implemented this assay for the quantification of Salmonella. A polyclonal 
antibody (specific for cell-wall epitopes) was incubated with freshly-prepared cells and subsequently 
passed through a syringe filter (0.22 m), enabling unbound antibody to be separated from antibody-
pathogen complexes. Free antibody was then captured on an anti-Fab-coated CM5 Biacore chip. This 
novel assay format permitted five different strains to be detected at similar sensitivities 
(1 × 10
4 CFU/mL), and allowed comparative analysis with an additional ten unrelated strains at high 
concentrations (1 × 10
8 CFU/mL) to be performed. No response of any statistical relevance was 
observed, illustrating the versatility of the SIA assay format to be used for selective analysis. Leonard 
et al. [28] developed a SIA assay for L. monocytogenes but adopted a different approach. A polyclonal 
antibody, produced through the immunisation of a rabbit with heat-treated cells, was purified by 
protein G affinity chromatography and added to differing concentrations of heat-killed cells in 
phosphate buffered saline solution (PBS) and incubated at 37C for 20 minutes. A centrifugation step 
was used as an alternative to filtration for the separation of free polyclonal antibody, and subsequent 
analysis was performed on a goat anti-rabbit polyclonal antibody immobilised on a CM5 surface. The 
efficacy of this assay format was illustrated by the low limit of detection (1 × 10
5 cells/mL), and by the 
short assay time required to obtain data (30 minutes; excluding preparation of the sensor surface).  
 
 Sensors 2009, 9                  
 
 
4425
 
12. Immunosensor-Based Assays for the Detection of Other Bacterial Pathogens 
 
A selection of immunosensor-based analytical platforms has also been developed for the detection 
of other bacterial pathogens, including Yersinia pestis, Vibrio cholerae, Mycobacterium tuberculosis 
and Brucella abortus (Table 4). Furthermore, an increase in public concern has resulted from the 
elevated numbers of nosocomial infections which have been caused by bacterial strains such as 
Clostridium difficile  and methicillin-resistant S. aureus  (MRSA). The latter bacterial strain produces 
17 enterotoxins [2] and several immunosensor platforms have enabled the detection of Staphylococcal 
enterotoxin B (SEB). Harteveld and co-workers [104] developed a piezoelectric immunosensor for 
detecting 0.1 g/mL of SEB through the development of a competition assay.  
Table 4. Immunosensor-based detection of selected bacterial pathogens. Key: [C] - capture 
antibody; [S] - secondary antibody; [D] - detection antibody. 
Bacterial 
strain 
Biosensor 
format 
Assay 
format 
Antibodies Sensitivity  Ref. 
B. anthracis  Optical   Sandwich  Biotinylated rabbit anti-B. anthracis 
polyclonal [C]; rabbit anti-B. anthracis 
polyclonal CY5 [D] 
3.2 × 10
5 
spores/mg powder 
[108] 
  Piezoelectric  Capture  Rabbit polyclonal anti-B. anthracis [C] 333  spores/mL  [109] 
B. globigii  Optical Sandwich  Goat  anti-B. globigii [C]; rabbit anti-B. 
globigii [S]; goat anti-rabbit-AP [D] 
1 spore  [110] 
B. subtilis  Potentiometric  Sandwich  Biotinylated polyclonal anti-B. subtilis 
antibody [C]; fluorescein-labelled 
polyclonal anti-B. subtilis antibody [S]; 
anti-fluorescein urease-conjugated 
antibody [D] 
3 × 10
3 spores/mL [111] 
F. tularensis Magnetic  Sandwich  Monoclonal  anti-F. tularensis [C]; 
biotinylated monoclonal anti-F. tularensis 
on streptavidin-coated magnetic beads [D] 
1 × 10
4 – 1 × 10
6 
CFU/mL 
[112] 
M. tuberculosis  Piezoelectric Capture Rabbit  anti-M. tuberculosis [C]  1 × 10
5 cells/mL  [113] 
  Voltammetric  Sandwich  Biotinylated rabbit anti-M. tuberculosis 
[C]; murine monoclonal anti-M. 
tuberculosis [S]; rabbit anti-mouse-AP [D] 
1.0 ng/mL  [114] 
N. meningitidis  Optical Direct  Murine  anti-group C polysaccharide [C]  -  [115] 
V. cholerae  Amperometric  Sandwich  Rabbit polyclonal anti-V. cholerae [C]; 
mouse anti-V. cholerae [S]; anti-mouse AP 
[D] 
1 × 10
5 cells/mL  [116] 
 Optical  Capture  Monoclonal  anti-V. cholerae O1 [C]  1 × 10
5 – 1 × 10
9 
cells/mL 
[117] 
Y. pestis  Magnetic  Sandwich  Monoclonal anti-F1 antigen [C]; 
biotinylated monoclonal anti-F1 on 
streptavidin-coated magnetic beads [D] 
2.5 ng/mL antigen  [118] 
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The capture of a rabbit polyclonal antibody on the sensor surface did not permit the detection of 
free SEB. The researchers, therefore, immobilised the toxin and subsequently passed over varying 
concentrations of antibody pre-incubated with the toxin. The response generated was inversely 
proportional to the concentration of free antigen in solution. A rapid (less than 10 minutes) fibre-optic 
SPR-based assay was also developed by Slavík et al. [105], capable of detecting 10 ng/mL of SEB. 
Immobilisation of antibodies (polyclonal) was facilitated by glutaraldehyde coupling. Moreno-Bondi 
and colleagues [106] reported that it was possible to detect femtogram (fg) quantities of human serum 
antibodies against SEB using an array biosensor (other antigens detected in this study included 
diphtheria toxin, hepatitis B surface antigen (HBsAg) and tetanus toxin), while a SPR-based assay, 
reported by Subramanian et al. [107] permitted the detection of whole S. aureus cells in direct and 
sandwich assay formats (1 × 10
5 CFU/mL). The sensor format used in this assay was the Reichert 
SR7000, with alkane monothiol and dithiol dendritic tether-based SAMs used for the capture of 
polyclonal antibodies via EDC/NHS coupling. 
 
13. Immunosensors for Fungal Pathogens and Mycotoxins 
 
The detection of fungal strains is of great importance, due to their association with crop spoilage 
and their involvement as human pathogens, and immunosensor-based technologies have been 
developed for their determination.  
A key consideration with analysing fungal cells relates to the fact that they are significantly larger 
than their bacterial counterparts, with fungal spores often over 40 micrometers in diameter [119]. This 
is understandably problematic in terms of system blockage. Hence, SIA assays, described earlier for 
bacterial strains [28,103], may be used to circumvent this problem.  
Skottrup et al. [120] pre-incubated a murine monoclonal antibody with sporangia of P. infestans at 
37C for 1 hour. The separation of bound and unbound antibody was permitted by a five minute 
centrifugation (1500g). Free antibody was then passed over a surface containing bound goat-anti-
mouse polyclonal antibody, allowing quantitation of free antibody. The limit of detection was 
2.2 × 10
6 sporangia/mL, and no cross-reactivity was seen when other fungal strains, such as 
Melampsora euphorbia and Botrytis cinerea were assayed in parallel. A similar assay was also used to 
detect spores of Puccinia striiformis, using a polyclonal rabbit anti-mouse IgM antibody to capture a 
mouse monoclonal IgM antibody produced from immunisation with whole urediniospores.   
Completion of the resultant assay took approximately 45 minutes with a detection level of 
3.1 × 10
5 urediniospores/mL [121]. Additional immunosensor formats have also been used for the 
detection of human fungal pathogens. Muramatsu et al . [122] applied a piezoelectric sensor for 
detecting Candida albicans through the immobilisation of an anti-Candida antibody on a palladium-
plated electrode. The recording of a loss in resonance frequency enabled the detection of 
1 × 10
6 CFU/cm
-3. Medyantseva and colleagues [123] targeted an antigenic determinant on 
Trichophyton rubrum with a polyclonal antiserum. Their amperometric immunoassay had a sensitivity 
of 1 × 10
-15 mg/mL of antigen and was rapid (20 minutes). 
The monitoring of the presence of aflatoxins, naturally occurring mycotoxins produced by several 
strains of Aspergillus spp. , in fruit, vegetable and food produce, is also of great significance. 
Aflatoxins can cause contamination of nuts (almonds, walnuts), cereals (rice, wheat, maize) and Sensors 2009, 9                  
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oilseeds (soybean and peanuts). While approximately 16 structurally diverse aflatoxins have been 
reported, aflatoxins B1, B2, G1 and G2 and M1 (Figure 7) represent the greatest danger to human 
health [124]. Daly et al. [125] used a rabbit polyclonal antibody to detect AFB1, which was conjugated 
to BSA and immobilised onto a CM5 Biacore chip. A competition assay between free and bound AFB1 
permitted a linear range of detection of trace levels (3 – 98 ng/mL). Daly and co-workers [126] 
subsequently generated murine scFvs against AFB1 by using a phage display format and incorporated 
these antibodies into a Biacore-based inhibition assay. Dunne et al. [127] also developed a SPR-based 
inhibition assay that incorporated monomeric and dimeric scFv antibody fragments for permitting the 
detection of between 390 and 12,000 ppb and 190 and 24,000 ppb of AFB1 with monomeric and 
dimeric scFvs, respectively. Adányi et al . [128] developed an optical wavelength lightmode 
spectroscopy (OWLS)-based assay for the detection of AFB1 and ochratoxin A. Integrated optical 
wavelength sensors were used in conjunction with murine monoclonal antibodies, with the sensitive 
detection range for a competitive assay being between 0.5 and 10 ng/mL. An indirect screening 
protocol was subsequently applied for the detection of these toxins in wheat and barley samples. 
Figure 7. Structures of commonly encountered aflatoxins. 
 
 
14. Immunosensor Assays for the Detection of Viral Pathogens, Marine Toxins and Parasites 
 
The versatility of immunosensor-based analytical platforms for pathogen detection is further 
illustrated by the ability to develop assays for the sensitive detection of viral pathogens (Table 5). 
These include Hepatitis-C virus, the severe acute respiratory syndrome (SARS) virus and bovine 
diarrhoeal virus, whose particles present an additional selection of structurally diverse epitopes which 
can be targeted by antibodies. Single-celled phytoplankta play important roles in the aquatic 
environment by providing nourishment for a selection of heterotrophic marine animals. These include 
filter-feeding bivalve molluscs, such as mussels, clams and scallops. Among the reported 5,000 species 
of marine phytoplankton, 300 have been postulated to occur in high-numbers, causing harmful algal 
blooms (HABs) or ‘red-tide’ events. Approximately 40 of these species produce secondary 
metabolites, collectively referred to as phycotoxins [129], that are structurally diverse and non-
proteinaceous compounds which have low molecular weights (in contrast to whole cell pathogens). Sensors 2009, 9                  
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They pose a considerable risk to human health by causing respiratory, neurological or gastrointestinal 
problems at low concentrations. The primary route of infection is through the ingestion of 
contaminated shellfish meat or drinking water. Furthermore, HABs also have a devastating effect on 
the shellfish industry and algal blooms can also result in reduced tourist activity and concomitant 
economic losses. Several countries have established regulations and specific concentration limits for 
phycotoxinlevelsin  
seafood [130]. 
Table 5. A selection of immunosensor-based assays for viral pathogen detection. Key: [C] 
- capture antibody; [P] - primary antibody; [S] - secondary antibody; [D] - detection 
antibody. Where primary antibodies are used, the antigen/epitope is immobilised on the 
sensor surface. 
Virus 
Biosensor 
platform 
Assay 
format 
Antibodies Ref. 
Herpes simplex virus (HSV) 1 
and 2, Varicella-Zoster virus 
(VSV), Cytomegalovirus (CMV) 
and Epstein-Barr virus (EBV) 
Piezoelectric  Capture  Mouse monoclonal antibodies to herpes 
simplex virus 1 and 2, cytomegalovirus, 
Epstein-Barr virus and Varicella Zoster 
virus [C] 
 
[131] 
Foot and mouth virus (FMV)  Impedimetric  Indirect  Murine monoclonal [P]   [132] 
African swine fever virus (ASF)  Piezoelectric  Capture  Murine monoclonal [C]   [133] 
Bovine diarrhoeal virus (BVD)  Optoelectronic  Capture  Anti-BVD monoclonal   [134] 
Cymbidium mosaic potexvirus 
(CymMV) and Odontoglossum 
ringspot tobamovirus (ORSV) 
Piezoelectric Capture  Rabbit  polyclonal
 
 
 
[135] 
SARS-associated coronavirus 
(SARS-CoV) 
Piezoelectric  Capture  Horse polyclonal anti-SARS-CoV [C]  [136] 
Human immunodeficiency virus 
(HIV-1) 
Piezoelectric Capture  Murine  anti-trans activator of transcription 
(TAT) HIV [C]  
[137] 
Hepatitis C virus (HCV)  Optical  Indirect  Polyclonal IgG antibodies [P]; Polyclonal 
goat anti-human IgG-HRP [D]  
[138] 
Cowpea mosaic virus (CPMV)  Optical  Capture  Anti-CPMV recombinant antibody (scFv) 
fused to the constant light chain (CL) 
domain containing a C-terminal cysteine 
residue [C]  
[139] 
Ebola virus (EBOV)  Optical 
 
QCM 
Capture 
 
Capture 
Mouse monoclonal anti-EBOV [C]  
Rabbit polyclonal antibody [C] or Mouse 
monoclonal antibody [C]  
[140] 
Avian leucosis virus (ALV)  Optical  Capture  Monoclonal anti-ALV-J   [141] 
Rift valley fever virus (RVF)  Fibre optic 
immunosensor 
Sandwich  Mouse polyclonal anti-RVF [C]; 
Polyclonal IgG antibodies [S]; Goat anti-
human IgG – HRP [D]  
[142] 
West Nile virus (WNV)  Amperometric  Indirect  Polyclonal IgG antibodies [P]; Goat anti-
human IgG-HRP [D] 
 
[143] 
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Phycotoxin groups are classified according to the associated symptoms of infection, and a selection 
of structures is shown in Figure 8. Paralytic shellfish poisoning (PSP)-associated toxins are water 
soluble, thermostable tetrahydropurine molecules which are subdivided into four structural categories, 
namely carbamate, N-sulphocarbamoyl, decarbamoyl and dideoxycarbamoyl. The most commonly 
encountered PSP-causing toxins are gonyatoxin (GTX) and saxitoxin (STX). The latter is especially 
toxic, and over 20 structural analogues with differing degrees of toxicity have been reported in 
nature [144]. A causative agent of amnesic shellfish poisoning (ASP) is domoic acid, a potent kainoid 
neuro-excitatory toxin which is synthesised by the marine diatom Pseudo-nitzchia pungens [145] and 
functions by binding to specialised receptors and inducing depolarisation of neuronal cells. 
Diarrheic shellfish poisoning (DSP) originates from the consumption of shellfish material 
contaminated with the polycyclic ether toxins okadaic acid (OA), dinophysis-toxin 1 (DTX1) and 
pectenotoxins (PTX). Yessotoxin (YTX) is also classified under this grouping as it was isolated in 
1987 from scallops associated with a DSP-related poisoning event. However, it was noted that the 
pharmacological properties of YTX differed from those of DSP toxins [146]. Okadaic acid, DTX and 
PTX are all produced by dinoflagellates belonging to the Dinophysis  and  Prorocentrum  species, 
whereas YTXs are synthesised by Protoceratium reticulatum [147]. Finally, cyanobacterial poisoning 
is caused by the hepatoxins microcystin (MC) and nodularin during red-tide events. Several bacterial 
species have been identified as being causative agents, including members of the geni Microcystis, 
Anaebaena and Planktothrix and consumption of contaminated water supplies is the primary route of 
infection [148]. 
Figure 8. Structures of commonly encountered phycotoxins. 
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A small number of immunosensor-based formats for the monitoring of phycotoxins have been 
developed (Table 6), and these have mainly focussed on BTX, DA, MC, OA and STX. Several factors Sensors 2009, 9                  
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have contributed to this low number. A key factor is the scarcity of sufficiently pure toxin for antibody 
generation and the poor supply of reference material for assay development [149]. This has been 
problematic in the development of immunosensor-based assays for detecting other important   
marine toxins. 
Azaspiracid (AZP) shellfish poisoning was first reported in 1995 in the Netherlands and was 
attributed to the consumption of mussels (Mytilus edulis) which were originally cultivated in Killary 
harbour, Ireland [163]. A total of 27 congeners of AZP have been characterised [164], and the 
producing strain has been postulated to be the dinoflagellate Protoperidinium  spp. [165]. No 
antibodies have been developed against this target in its natural state, although an ELISA using an 
ovine polyclonal antibody against a synthetic AZA hapten was reported [166]. The availability of more 
reference material should permit additional assays to be developed for this and other marine toxins. 
Another important aspect for antibody-based marine algal toxin detection relates to the structural 
similarity that exists between toxin congeners. Furthermore, if a mixture of toxins is analysed in an 
immunosensor format, underestimation or overestimation of toxicity may occur as a result of an 
antibody being able to recognise multiple isomers of the same toxin molecule. This suggests that 
suitable antibody candidates have to be rigorously screened to ensure that cross-reactivity does not 
occur. Finally, biosensors for marine toxins should permit the detection of a toxin in a complex matrix, 
such as shellfish meat. The formats described in Table 6 were developed in an attempt to replace the 
current regulated methods of marine toxin detection, including the mouse bioassay and high-
performance liquid chromatography-mass spectrometry (HPLC-MS). It remains to be seen whether 
they will be incorporated into legislation or routine monitoring programmes in the near future. 
Table 6. A selection of immunosensor-based assays for marine algal toxin detection. Key: [C] - 
capture antibody; [P] - primary antibody; [D] - detection antibody; LOD - limit of detection.  
Toxin Biosensor 
Format 
Assay 
Format 
Antibodies LOD  Ref 
Brevetoxin  Amperometric  Indirect  Goat-anti brevetoxin [P]  15 g/L [150] 
Domoic acid  Amperometric  Indirect  Sheep polyclonal [P]; anti-sheep IgG-AP [D]  2 g/L [151] 
(DA)  Amperometric  Indirect  Rabbit polyclonal [P]  0.1 g/L [152] 
  Optical  Indirect  Monoclonal anti-DA [P]  1.8 g/L [153] 
  Optical  Indirect  Monoclonal anti-DA [P]  0.1 g/L   [154] 
  Optical  Indirect  Rabbit polyclonal anti-DA [P]  3 g/L [155] 
Microcystin-LR  Optical  Direct  Monoclonal anti-MC-LR-Cy5 [P]  0.03 g/L [156] 
(MC)  Capacitance  Capture  Monoclonal anti-MC-LR [C]  7 pg/L  [157] 
  Optical  Direct  Monoclonal anti-MC-LR-Cy5 [P]  30 ng/L  [158] 
Okadaic acid  Optical  Direct  Mouse monoclonal anti-OA-HRP [P]  0.1 g/L [159] 
(OA)  Amperometric  Direct  Mouse monoclonal anti-OA-AP [P]  1.5 g/L [151] 
  Piezoelectric  Capture  Monoclonal anti-OA [C]  3.6 g/L   [160] 
  Amperometric  Capture  Monoclonal anti-OA [C]  2 g/L [161] 
  Amperometric  Indirect  Mouse monoclonal anti-OA [P]; goat anti-
mouse-HRP or AP [D] 
0.03 g/L [162] 
Saxitoxin (STX)  Amperometric  Direct  Donkey anti-STX-glucose oxidase [P]  2 g/L [150] 
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Immunosensor-based assay formats have allowed the detection of a selection of water-borne 
parasites. A piezoelectric assay was described by Campbell and Mutharasan [167] for the detection of 
between 100 and 10,000 oocysts/mL of Cryptosporidium parvum, while Kang and co-workers [168] 
developed a Biacore-based immunosensor assay which allowed the detection of between 1 × 10
2 – 
1 × 10
6 oocysts/mL. The flexibility of using this methodology has also been illustrated by the ability to 
also detect other parasitic pathogens, including Schistosoma japonicum  [169-172] and Borrelia 
burgdorferi [173], which act as causative agents of schistosomaisis and lyme borreliosis, respectively. 
These assays use amperometric [169-171], piezoelectric [172] and optical [173] -based platforms.  
 
15. Antibody-Based Biosensors: Potential Issues 
 
This review has outlined the principles and practices of antibody-based sensors for facilitating the 
detection of bacterial, fungal and viral species and toxins. A wide range of different applications have 
been highlighted involving the use of polyclonal and monoclonal antibodies (and, to a lesser extent, 
recombinant antibodies). However, it should also be emphasised that several problems may need to be 
addressed when developing related sensor-based assays, and these are now discussed. 
Several of the aforementioned assays have also focused on a particular antigen. While this is also 
the most effective method for ensuring specificity, this may also be detrimental in instances where the 
exposure of a bacterial strain to stress, such as osmotic shock, alterations in pH or temperature 
fluctuations, or different growth media (e.g. different food matrices) may compromise the expression 
of a selective antigen. Hahm and Bhunia [174] exposed cells of L. monocytogenes, Salmonella spp. 
and E. coli  O157:H7 to a variety of stress conditions and noted that antibody-based responses were 
reduced. Hearty and colleagues [6] heat-treated L. monocytogenes cells and assayed these alongside 
untreated cells on a monoclonal antibody-immobilised Biacore surface. A significant decrease in 
signal was observed when cells were treated at 60C for 10 minutes, an observation putatively 
attributed to an alteration in the topography of the bacterial cell wall introduced by this treatment. 
These observations postulate that the sensitivity of an antibody may be compromised by an external 
factor, reiterating the importance of bacteriological propagation considerations. This point is 
particularly important in cases where antibodies are unable to differentiate between viable and non-
viable cells, with active culturing able to circumvent this problem. 
Several of the assays described in this review have been performed on SPR-based analytical 
platforms, and have involved the detection of bacterial and fungal cells whose sizes are typically 
between 1 – 5 micrometers and in excess of 40 micrometers, respectively [119]. Capture formats are 
typically used, involving the immobilisation of an antibody and the subsequent capture of a cell and, if 
deemed necessary, the addition of secondary antibody to enhance sensitivity [89,101,102]. In Biacore-
based analytical systems, the depth at which a SPR-produced evanescent wave can penetrate when TIR 
occurs is 0.3 m [28,101]. Hence, the direct immobilisation of large bacteria and fungal cells, whose 
diameters exceed this area, might compromise detection. Conversely, in the cases where bacterial cells 
are captured on immobilised antibodies, the whole bacterial cell will not be contained within this area, 
implying that only a portion of the cell will be able to contribute towards a RI change. This 
observation may explain why shorter dextran chain lengths, such as those selected by Bokken Sensors 2009, 9                  
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et al. [102] (F1 or CM3 Biacore sensor chips) may be more suitable as, in theory, the bacterial cell is 
spatially arranged closer to the surface and, hence, is more exposed to the evanescent wave field.  
It is also worth noting that Biacore detection systems typically monitor SPR angles on the sensor 
surface over an area of 0.25 mm
2 [101]. This implies that a reduced SPR signal may arise from large 
cells sterically hindering each other if present in large amounts. This problem can be addressed by 
monitoring the sensor surface by atomic force microscopy (AFM), as discussed by Hearty et al. [6] 
who were able to undock a CM5 chip, containing L. monocytogenes  cells bound to a monoclonal 
antibody, incubate overnight in a glutaraldehyde-cacodylate buffer and fix in the presence of osmium 
tetroxide. Dehydrated chips, treated with ethanol, could then be analysed to monitor surface 
topography. Finally, it is worth mentioning that ELISA and Biacore-based assays differ from each 
other in that the former typically involves a ‘static’ incubation of antibody and pathogen, while 
Biacore, and indeed several other assay formats, have additional considerations, including fluid forces. 
It is therefore of great importance that the antibody selected has sufficient affinity to allow cells to be 
captured and, most importantly, retained to permit further analysis [28]. This limitation effect can be 
overcome thorough the use of low flow-rates, such as 1 L/minute [6]. 
 
16. Alternative Sensor-Based Platforms for Pathogen Detection 
 
Biomimetic sensors (e.g. ‘electronic noses’ and ‘electronic tongues’) and plant sensors can be 
selected as alternative methodologies to immunosensors for detecting pathogens. Electronic noses are 
comprised of sensor arrays that are capable of detecting a selection of compounds (e.g. ketones, 
aldehydes, aromatic and aliphatic compounds) produced during the growth stages of bacterial strains 
on a certain substrate. Needham and colleagues [175] were able to detect one bacterial (B. subtilis) and 
two fungal strains (Penicillium verrucosum, Pichia anomala) on bread before visible signs of spoilage 
were observed. Lipoxygenase-based enzymatic spoilage could also be differentiated from microbial 
spoilage, and this methodology was coupled with gas chromatography-mass spectrometry (GC-MS) 
for characterisation of the ‘volatiles’ (e.g. 1-butanol, 2-butanone) produced during growth of these 
strains. Alocilja et al. [176] were able to differentiate strains of E. coli O157:H7 from unrelated E. coli 
strains by monitoring the gaseous products produced when cells were propagated in a nutrient broth 
liquid culture. The electronic nose-based sensor chamber incorporated four metal-oxide gas sensors for 
the detection of volatile products of E. coli  growth, such as amines, ketones and alcohols. This 
investigation allowed the researchers to demonstrate that E. coli O157:H7 had a different gas signature 
pattern from the unrelated strains tested in parallel. Furthermore, Balasubramanian and co-workers 
were able to detect S. typhimurium in spiked vacuum-packed beef striploins (2.6 CFU/g beef) [177]. In 
contrast, electronic tongues focus on the analysis of liquid samples, and are applicable for the analysis 
of food quality [178]. This biomimetic sensor format was selected by Lan and colleagues for the 
detection of S. typhimurium (1 × 10
6 CFU/mL) in chicken carcass samples [179].  
Non-antibody biomimetic receptor molecules, including engineered proteins, peptides, aptamers 
(single stranded DNA or RNA), ribozymes or synzymes (synthetic enzymes), also have potential in the 
detection of pathogens and other food contaminants [180]. A piezoelectric biosensor using 
oligopeptides designed to mimic the binding site of the aryl hydrocarbon receptor (dioxin receptor) 
protein was used to sensitively detect dioxins (1 – 20 ppb) [181]. Similarly, surface-immobilised Sensors 2009, 9                  
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antimicrobial peptides (e.g. polymyxins B and E) were used to detect S. typhimurium (5 × 10
4)
 and E. 
coli O157:H7 (1 × 10
5 CFU/mL) in direct and sandwich assay formats [182]. Pan et al. [183] reported 
the successful detection of S. enterica serovar Typhi by using a single-stranded RNA aptamer (S-PS8.4) 
that bound to pili (type IVB) expressed on the bacterial cell that were instrumental in promoting 
pathogenesis.  
The ability of plants sensors (phytosensors) to detect environmental conditions and plant pathogens 
is still in its infancy in terms of sensor technology. A phytosensor capable of detecting plant pathogens 
at the molecular level was described by Mazarei and co-workers [184]. Transgenic tobacco plants, 
containing an inducible plant defense mechanism linked to the β-glucuronidase reporter gene, 
inoculated with Alfalfa mosaic virus showed increased β-glucuronidase expression.  
These examples demonstrate that the combination of synthetic receptors mimicking nature with 
desired transducers can be selected as an alternative to immunosensor-based analysis for pathogen 
detection, although further development will be needed before these alternative formats are selected 
above immunosensor platforms for pathogen analysis. 
 
17. Conclusions 
 
The importance of antibodies as biorecognition elements for pathogen detection was discussed. 
Antibody-based sensors can provide robust, sensitive and rapid analysis. In most cases the key element 
is the quality of the antibody used and recombinant antibodies have many advantages, including the 
ability to be genetically modified to improve selectivity, sensitivity and immobilisation. In practice, 
the development of these assays is simplified through the development of a suitable antibody and, 
subsequently, an assay format. While there are several problems associated with these methods, the 
potential for monitoring bacterial, fungal, viral and parasitic pathogens is immense.  
Innovative recent developments, such as the hand-held device described recently by Mujika 
et al. [85], signal the way forward for pathogen detection. Future trends will continue to implement 
immunosensor-based technologies into microdevices, ultimately permitting on-site analysis to be 
performed in a rapid, reliable and sensitive manner. 
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